US Stocks
/
Immix Biopharma, Inc. Share Price

Immix Biopharma, Inc. Share Price

NASDAQ: IMMX | Small Cap
$12.71
+$0.80 (6.76%) Last updated on 18 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Immix Biopharma, Inc. Stock Performance

Open
$12.13
Prev. Close
$11.91
Circuit Range
N/A
Day Range
$12.13 - $12.72
Year Range
$1.97 - $15.09
Volume
81,025
Average Traded
$12.42

Immix Biopharma, Inc. Share Price Today

As of 18 September 2026, Immix Biopharma, Inc.'s share price is $12.71. The stock opened at $12.13, compared to its previous close of $11.91. During today's trading session, Immix Biopharma, Inc.'s share price traded between $12.13 and $12.72, with an average price of $12.43. Over the past 52 weeks, the stock has recorded a high of $15.09 and a low of $1.97. In terms of performance, Immix Biopharma, Inc.'s share price has risen by 39.27% over the last six months and is up 508.37% on a year-on-year basis.

Immix Biopharma, Inc. Share Price Chart

$12.13$12.72
L
Show Current Price
H

Immix Biopharma, Inc. Stock Fundamentals & Key Indicators

Market Cap
$419.16M
PE Ratio (TTM)
-14.29
Dividend Yield
N/A
EPS (TTM)
$-0.89
Revenue (TTM)
N/A
Return On Equity (TTM)
-31.39%
Profit Margin
N/A
Debt to Equity
0.11
Quarterly Earnings Growth YoY
-72.68%

Immix Biopharma, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsJun 2024Sep 2024Jun 2025Sep 2025
RevenueN/AN/AN/AN/A
Net Profit-$4.39M-$7.15M-$6.62M-$7.59M
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-62.75%7.37%-14.54%

Immix Biopharma, Inc. Annual Profit & Loss

All figures in USD

Particulars202220232025
RevenueN/AN/AN/A
Net Profit-$8.23M-$15.43M-$29.44M
Net Profit MarginN/AN/AN/A
Income ChangeN/A-87.44%-90.84%

About Immix Biopharma, Inc.

Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.

Immix Biopharma, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$14.03
$12.71
-11.06%
Aug 2026
$8.31
$14.29
+71.65%
Jul 2026
$10.19
$8.32
-19.10%
Jun 2026
$8.93
$10.29
+14.52%
May 2026
$8.91
$8.98
+0.50%
Apr 2026
$9.43
$8.94
-2.08%
Mar 2026
$8.11
$9.13
+13.42%
Feb 2026
$5.78
$8.05
+38.44%
Jan 2026
$5.24
$5.82
+11.61%
Dec 2025
$4.22
$5.21
+22.01%
Nov 2025
$3.77
$4.27
+12.66%
Oct 2025
$2.10
$3.79
+81.34%

IMMX Share Price FAQs

What is Immix Biopharma, Inc. share price today?

chevron-up
Immix Biopharma, Inc. share price today is $12.71 as on September 18, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Immix Biopharma, Inc. stock?

chevron-up
The 52 week high of Immix Biopharma, Inc. stock is $15.09, while the 52 week low is $1.97 as of 18 Sep '26.

What is IMMX's market capitalisation today?

chevron-up
IMMX market capitalisation is $419.16M as of September 18, 2026, at 1:41 pm IST.

What is IMMX's net income for the last quarter?

chevron-up
IMMX's net income for the last quarter is -0.01B USD.

What is the 5 year returns of IMMX?

chevron-up
The 5 year returns of IMMX is 257.16% as on 18 Sep '26.

What is the high & low stock price of IMMX today?

chevron-up
IMMX stock price hit a high of $12.72 and low of $12.13 as of 18 Sep '26.

Can I buy IMMX shares in India?

chevron-up
Yes. You can buy IMMX in India by opening an international trading account.